#organ transplantation market

[mi-researchreports]

Transplant Diagnostics Market is poised to grow at CAGR of 7.8 % by 2027. Factors driving the Transplant Diagnostics Market are rising number of organ transplant tests and funding for organ transplantation.

[hellenic-whore]

Thinking about how many refugees are having their organs trafficked solely because of the effects of US imperialism and colonialism on SWANA countries and many,many others

You all should read the red market by Scott carney

People don't talk about how much refugees and people in similar situations are taken advantage of in ways like this.

Linking to a post I made about this issue earlier as well

[healthcareporium]

Immunomodulators' Power: Widening Applications and Medical Impact

Immunomodulators have emerged as crucial components in the field of medicine, gaining increasing attention for their ability to regulate and modify the immune system’s responses. These agents play a pivotal role in treating a diverse range of conditions, from autoimmune diseases and cancer to infectious diseases and organ transplants. By modulating immune responses, immunomodulators offer…

[acumenblog]

Organ Transplant Rejection Medication Market to Grow with a 5.3% CAGR from 2023 to 2032, Expected to Reach USD 7.4 Billion by 2032

Acumen Research and Consulting has recently published a research report on the Organ Transplant Rejection Medication Market for the forecast period of 2023 – 2032, wherein, the global market has been analyzed and assessed in an extremely comprehensive manner. The research report on the Organ Transplant Rejection Medication Market offers an extensive analysis of how the postoperative pain…

[mitalipingale]

https://carbonfacesocial.org/blogs/89762/Organ-Transplant-Immunosuppressant-Drugs-Market-Size-Analysis-and-Forecast-2031

The Organ Transplant Immunosuppressant Drugs Market in 2023 is US$ 5.17 billion, and is expected to reach US$ 6.71 billion by 2031 at a CAGR of 3.30%.

[adlibitur]

mmm that uterus transplants normalize the idea that someone can be entitled to someone elses organs if they "arent using them (correctly)" and thats surely not a poor ethics path to go down (it 100000% is jfc and in fact a bit honestly handmaids tale though that analogy is used far too often)

[creativeera]

The Global Cell and Tissue Preservation Market will grow at highest pace owing to increasing research in cryopreservation

The global cell and tissue preservation market covers equipment, consumables, and media used for cryopreservation and preservation of cells and tissues. Cell & tissue preservation allows long-term storage of biological samples at ultra-low temperatures for future application in research activities, clinical diagnostics, and cell & tissue-based therapies. Cell preservation equipment help in controlled freezing and thawing required for cryopreservation of samples, while consumables are one-time use containers and media are solutions required for storage of biological materials. The increasing research in application of stem cells for disease treatment and growing demand for biobanking are fueling the need for cell & tissue preservation products.

Global Cell And Tissue Preservation Market is estimated to be valued at USD 5.11 Bn in 2024 and is expected to reach USD 10.82 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 11.3% from 2024 to 2031. 

Key Takeaways Key players operating in the global cell and tissue preservation market are Thermo Fisher Scientific, Inc., Lonza, BD, MerckKGaA, Cytiva, Agilent Technologies, Inc., Avantor, Inc., FUJIFILM Irvine Scientific, BioLifeSolutions Inc., AMSBIO, Princeton CryoTech, STEMCELL Technologies Inc., LGC SeraCare, Corning Incorporated, CellGenix GmbH. The global cell and tissue preservation market has seen rising demand due to increasing research in stem cell therapy and regenerative medicines. The number of clinical trials has increased multi-fold over the last decade. Preservation is vital for storage and transportation of biological samples used in these research studies and clinical applications. Technological advancements in cryopreservation process, equipment, and storage solutions are also fueling the Global Cell And Tissue Preservation Market Size. Automated freezing and controlled rate freezing equipment offer standardization and improve sample viability. Newer biomaterials provide better tissue preservation and enhance the capabilities of biobanks to store various sample types. Market trends: - Increased adoption of automated cell and tissue processing: Automation reduces manual errors and improves throughput and standardization in preservation workflow. - Growing preference for serum-free and animal-component free solutions: Developments are underway to address end-user demand for xeno-free formulations to avoid contamination. Market Opportunities: - Emerging economies in Asia Pacific and Latin America: Improving research infrastructure and increasing healthcare investments provide lucrative opportunities. - Umbilical cord blood and tissue banking: Expanding network of private and public banks worldwide augments demand for specialized preservation solutions. Impact of COVID-19 on Global Cell and Tissue Preservation Market Growth The outbreak of COVID-19 pandemic has significantly impacted the growth of Global Cell and Tissue Preservation Market Regional Analysis. During the initial lockdown period, hospitals and research institutes experienced supply chain disruptions as transportation restrictions were imposed globally. This led to shortage of raw materials such as preservation media for cell and tissue culture preservation. However, with increased focus on vaccine development and clinical testing, demand for preserved cell and tissue samples grew exponentially. Manufacturers responded swiftly by scaling up their production capacities and supply chains. Government funding for COVID-19 research also boosted the procurement of preservation products and equipment by biotech and pharmaceutical companies. Post lockdown, the market has witnessed growing demand from biobanks for long term preservation of COVID-19 testing samples as well as various cell lines used in vaccine development studies. The need to store clinical samples for future analysis has accelerated the adoption of automated banking equipment by government organizations. Moving forward, sustained research on virus pathogenesis and development of combination therapies will further augment the requirement for preserved biomaterials. Additionally, cell and tissue transplantation procedures deferred during peak pandemic period are being resumed, contributing to market revenues. Overall, COVID-19 has enhanced the significance of cell and tissue biobanking globally. Get more insights on Global Cell And Tissue Preservation Market

[bommagoni]

Organ and Tissue Transplantation Market Size, Forecast 2030

[sayruq]

Police in the Turkish city of Adana detained 11 suspects, five Israeli and two Syrian, on allegations of organ trafficking, the Daily Sabah reported on 5 May. The Provincial Directorate of Security's Anti-Smuggling and Border Gates Branch began investigating after examining the passports of seven individuals who arrived in Adana from Israel about a month ago by plane for the purpose of health tourism. The two Syrian nationals, ages 20 and 21, were found to have fake passports. Further investigation revealed that Syrian nationals had each agreed to sell one of their own kidneys to two of the Israeli nationals, ages 68 and 28, for kidney transplants in Adana. During searches at the suspects' residences, $65,000 and numerous fake passports were seized. Israel has long been at the center of what Bloomberg described in 2011 as a “sprawling global black market in organs where brokers use deception, violence, and coercion to buy kidneys from impoverished people, mainly in underdeveloped countries, and then sell them to critically ill patients in more-affluent nations.” The financial newspaper added, “Many of the black-market kidneys harvested by these gangs are destined for people who live in Israel.” The organ-trafficking network extends from former Soviet Republics such as Azerbaijan, Belarus, Ukraine, and Moldova to Brazil, the Philippines, South Africa, and beyond, the Bloomberg investigation showed. Accusations of Israeli involvement in organ trafficking also apply to the occupied Palestinian territories. In 2009, Sweden's largest daily newspaper, Aftonbladet, reported testimony that the Israeli army was kidnapping and murdering Palestinians to harvest their organs. The report quotes Palestinian claims that young men from the occupied West Bank and Gaza Strip had been seized by the Israeli army, and their bodies returned to the families with missing organs. "'Our sons are used as involuntary organ donors,' relatives of Khaled from Nablus said to me, as did the mother of Raed from Jenin as well as the uncles of Machmod and Nafes from Gaza, who all had disappeared for a few days and returned by night, dead and autopsied," wrote Donald Bostrom, the author of the report.Bostrom also cites an incident of alleged organ theft during the the first Palestinian intifada in 1992. He says that the Israeli army abducted a young man known for throwing stones at Israeli troops in the Nablus area. The young man was shot in the chest, both legs, and the stomach before being taken to a military helicopter, which transported him to an unknown location. Five nights later, Bostrom said, the young man's body was returned, wrapped in green hospital sheets. Israel’s Channel 2 TV reported that in the 1990s, specialists at Abu Kabir Forensic Medicine Institute harvested skin, corneas, heart valves, and bones from the bodies of Israeli soldiers, Israeli citizens, Palestinians, and foreign workers without permission from relatives. The Israeli military confirmed that the practice took place, but claimed, "This activity ended a decade ago and does not happen any longer." Israel’s assault on Gaza since 7 October has provided further opportunities for the theft and harvesting of Palestinians’ organs. On 30 January, WAFA news agency reported that the Israeli army returned the bodies of 100 Palestinian civilians it had stolen from hospitals and cemeteries in various areas in Gaza. According to medical sources, inspection of some of the bodies showed that organs were missing from some of them. On 18 January, the Times of Israel reported that the Israeli army confirmed reports that its soldiers dug up graves in a Gaza cemetery, claiming its soldiers were trying to “confirm that the bodies of hostages were not buried there.”

[123567-9qaaq9]

Advancements in Organ Transplant Diagnostics: Paving the Way for Precise and Successful Transplants

Introduction:

Organ transplantation has undoubtedly revolutionized the field of medicine, offering a second chance at life for those suffering from end-stage organ failure. However, the success of organ transplantation relies heavily on accurate diagnostics to ensure compatibility between donors and recipients. In recent years, the Organ Transplant Diagnostics Market has witnessed significant advancements, playing a pivotal role in enhancing transplant outcomes.

The Growing Need for Organ Transplants:

The demand for organ transplants continues to rise globally, driven by an aging population, increased prevalence of chronic diseases, and improvements in surgical techniques. As the number of transplant procedures increases, so does the importance of precise and reliable diagnostics to match donors and recipients effectively.

Key Market Drivers:

Technological Innovations: The field of organ transplant diagnostics has experienced a surge in technological advancements. Molecular diagnostics, genomics, and next-generation sequencing techniques have revolutionized the way organ compatibility is assessed, allowing for more accurate matching and reducing the risk of rejection.

Rising Incidence of Chronic Diseases: Conditions such as chronic kidney disease, liver cirrhosis, and heart failure contribute significantly to the need for organ transplants. With a growing population affected by these diseases, the demand for reliable diagnostic tools has become paramount.

Global Organ Shortage: The scarcity of organs for transplantation remains a major challenge. Efforts to expand the donor pool and increase organ availability have intensified, emphasizing the need for advanced diagnostic solutions to maximize the utilization of available organs.

Market Segmentation:

The Organ Transplant Diagnostics Market can be segmented based on technology, product type, and application. Molecular assays, serological assays, and next-generation sequencing are among the key technologies employed for assessing organ compatibility. Products include reagents and consumables, instruments, and software services. Applications cover kidney, liver, heart, lung, and other organ transplants.

Challenges and Opportunities:

Immunological Complexity: The intricate nature of the human immune system poses challenges in achieving precise organ matches. Ongoing research aims to unravel the complexities of immunology, providing opportunities for more targeted and effective diagnostic solutions.

Cost Constraints: The high cost associated with organ transplant diagnostics can be a limiting factor, particularly in developing regions. Industry stakeholders are actively working towards cost-effective solutions to broaden access and affordability.

Future Outlook:

The future of organ transplant diagnostics holds promise, with ongoing research focusing on personalized medicine and innovative diagnostic approaches. Artificial intelligence and machine learning are expected to play a significant role in predicting transplant outcomes and optimizing organ allocation.

To understand better download the sample page @ https://bisresearch.com/requestsample?id=1493&type=download

Conclusion:

The Organ Transplant Diagnostics Market is witnessing a paradigm shift, with advancements in technology and a deeper understanding of immunology. As the demand for organ transplants continues to grow, the role of precise and reliable diagnostics becomes increasingly vital. The collaborative efforts of researchers, healthcare professionals, and industry stakeholders are driving the market forward, offering hope for improved transplant outcomes and ultimately saving more lives.

[healthcaretechnologynews]

Transplantation Market by Products (Tissue Products, Immunosuppressive Drugs), Application (Tissue Transplantation, Organ Transplantation), End User (Hospitals, Transplantation Centers) – Global Outlook & Forecast 2023-2031

According to the deep-dive market assessment study by Growth Plus Reports, the global transplantation market was valued at US$ 14.92 billion in 2022 and is expected to register a revenue CAGR of 9.47% to reach US$ 33.68 billion by 2031.

Transplantation Market Fundamentals

Transplantation, or organ transplantation, is a medical procedure in which a healthy organ or tissue is surgically removed from one person, known as the donor, and placed into another person, known as the recipient. Transplantation aims to replace a failing or damaged organ with a functional one, thereby improving or restoring the recipient's health and quality of life. Organ transplantation has become a life-saving option for individuals with end-stage organ failure, where other treatments have failed or are no longer effective. Common organs that can be transplanted include the heart, kidneys, liver, lungs, pancreas, and intestines. In addition, tissues such as corneas, skin, bone, and bone marrow can also be transplanted.

Transplantation has revolutionized medical care and significantly improved the survival rates and quality of life for many patients with organ failure. Efforts are ongoing to increase organ donation rates, promote organ sharing, and develop alternative approaches such as xenotransplantation and regenerative medicine techniques to address the shortage of organs.

Get Free Sample PDF including full TOC, Tables and Figures, and Available customizations: https://www.growthplusreports.com/inquiry/request-sample/transplantation-market/9283

Transplantation Market Dynamics

The prevalence of organ failure, such as end-stage renal disease, liver cirrhosis, heart failure, and lung disease, is rising globally. The growing incidence of these conditions fuels the demand for organ transplantation as a life-saving treatment option. According to the European Society of Cardiology, in the span of 1990-2017, the number of patients with heart failure doubled from 33.5 million to 64.3 million. Additionally, advances in surgical techniques, immunosuppressive medications, and organ preservation methods have improved the success rates of transplantation procedures. These advancements have made transplantation viable for a broader range of patients, increasing the demand for transplants and thus boosting the global transplantation market. Furthermore, efforts to expand the organ donor pool have contributed to the growth of the global transplantation market. This includes initiatives to increase deceased organ donation rates, living donor programs, and the use of extended criteria donors (ECDs) or marginal organs that may not have been considered suitable in the past.

However, the demand for organs far exceeds the available supply, leading to long waiting lists and significant challenges in organ allocation. The need for more organs restricts the number of transplantation procedures that can be performed and limits the market's growth potential. For instance, according to the Health Resources & Services Administration, each day, 17 individuals die while waiting for an organ transplant, and another person is added to the waiting list every 10 minutes. Transplantation procedures are complex and expensive, involving pre-operative evaluations, surgical procedures, post-operative care, immunosuppressive medications, and long-term follow-up. The high cost of transplantation can create financial barriers for patients, limiting access to transplantation and impacting market growth. Moreover, despite advancements in immunosuppressive medications, organ rejection remains a significant concern in transplantation. The recipient's immune system can recognize the transplanted organ as foreign and mount an immune response, potentially leading to organ failure. The need for lifelong immunosuppressive therapy can have side effects and complications, affecting patient outcomes. Additionally, organ shortage, rejection, and high procedure costs are some of the restraints impeding the overall market growth.

Transplantation Market Ecosystem

The global transplantation market is analyzed from the following perspectives: products, application, end user, and region. 

Transplantation Market by Products 

Based on the products, the global transplantation market is segmented into tissue products, preservation solutions, and immunosuppressive drugs.

The tissue products segment dominated the market with a principal revenue share of 55.4% in 2022. The increasing number of transplantation procedures, such as cochlear, heart valves, bone marrow, and orthopedic soft tissues, is attributed to the segment’s growth. Tissue products are the numerous forms of human tissues used for transplantation. Tissue transplantation involves specific tissues, such as corneas, skin, bone, tendons, and heart valves, rather than whole organs. These tissues are obtained from deceased donors and can be used to replace or repair damaged or diseased tissues in recipients. The availability of high-quality tissue grafts, advancements in tissue preservation techniques, and ongoing research and development in tissue engineering contribute to the segment's growth.

Transplantation Market by Application 

Based on the application, the global transplantation market is segmented into tissue transplantation and organ transplantation.

The organ transplantation segment accounted for a prominent share of the market. Organ transplantation focuses on the transplantation of whole organs from deceased or living donors to recipients in need of organ replacement. Organ transplantation is a complex medical procedure involving the surgical removal of an organ from a donor and its implantation into the recipient's body. Organ transplant surgeries involve the transplantation of a whole organ, such as a heart, liver, kidney, lung, or pancreas, from the donor to the recipient. Highly skilled transplant surgeons lead the surgical procedures, often assisted by a specialized surgical team. The surgical techniques and protocols vary depending on the organ being transplanted. The organs for transplantation are obtained from deceased individuals who have consented to organ donation or living individuals who voluntarily donate an organ. Donor evaluation includes medical history review, physical examinations, and various tests to assess the health and suitability of the organs for transplantation. These factors contribute to the growth of the organ transplantation segment.

Transplantation Market by End User

Based on the end user, the global transplantation market is segmented into transplantation centers, hospitals, and others.

The hospitals segment is a key player in the transplantation market, with the largest revenue share of 51.2% in 2022, being the primary treatment center for the transplantation procedure. Hospitals play a crucial role in all aspects of the transplantation process, from patient evaluation and pre-transplant care to surgical procedures, post-operative care, and long-term follow-up. Hospitals that have specialized transplant centers are at the forefront of transplantation services. These centers typically have multidisciplinary teams consisting of transplant surgeons, transplant physicians, nurses, anesthesiologists, social workers, and other healthcare professionals collaborating to provide comprehensive care to transplant patients. Hospitals perform transplantation surgeries involving donor organs or tissue implantation into the recipient's body. Transplant surgeons lead the surgical procedures, working with a specialized surgical team to ensure the successful transplantation of the organ or tissue. Hospitals must maintain state-of-the-art surgical facilities and adhere to strict surgical protocols. These overall factors contribute to the growth of the hospital segment. 

Transplantation Market by Region

Geographically, the global transplantation market has been segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. 

North America dominated the global transplantation market with the largest revenue share of 41% in 2022, attributed to advanced healthcare infrastructure, robust research and development activities, and a high prevalence of transplantation procedures. For instance, according to the Organ Procurement and Transplantation Network, in the United States, 42,887 organ transplants were performed in 2022, setting a record. North America has well-established transplantation programs and centers of excellence that have significantly contributed to the field. These programs have extensive experience in organ transplantation, advanced surgical techniques, and comprehensive post-transplant care. The region has many transplant centres in academic institutions and private hospitals, providing various transplantation services. 

Additionally, regional companies are continuously involved in partnerships, mergers, and acquisitions, which are also expected to improve the transplantation market outlook. For instance.  North America is at the forefront of technological advancements in transplantation. The region has witnessed the development and adoption of innovative techniques, including minimally invasive surgeries, robotic-assisted surgeries, improved organ preservation methods, and advanced immunosuppressive therapies. These advancements have contributed to improved patient outcomes, shorter hospital stays, and reduced complications.

Transplantation Market Competitive Landscape

The prominent players operating in the global transplantation market are:

Arthrex, Inc.

Astellas Pharma

Zimmer Biomet

21st Century Medicine

Veloxis Pharmaceuticals Inc.

BiolifeSolutions, Inc. 

Orthofix Medical Inc.

Amnio Technology

Transplantation Market Strategic Developments

In July 2022, Precise Bio partnered with Carl Zeiss Meditec to develop and commercialize tissue-based implants for ophthalmology. The firms will collaborate to create 4D bio-fabricated corneal transplants for patients requiring endothelial keratoplasty and natural lenticular transplants to treat keratoconus and vision correction.

In February 2022, Amnio Technology, a global pioneer in the development and marketing of amniotic tissue allografts, introduced two new PalinGen membrane products, PalinGen Dual-Layer Membrane and Dual Layer PalinGen X-Membrane. Like the whole PalinGen membrane product line, the novel allografts are minimally modified, analogous in usage, and devoid of the chorion. The dual-layered structure of the allografts allows for unidirectional application with two epithelial sides facing outward. The PalinGen membranes are manufactured using the patented Advantek technology, which retains the extracellular matrix components and regulatory proteins found in amniotic tissues. Keeping the properties of natural tissue helps in wound treatment.

Visit our report store at https://www.growthplusreports.com/report-store

[incorrectbatfam]

Batfam as the excuses they gave to the school/teacher for robin activities.

Dick: "My brother threw away my disco suit so I have to go dumpster diving ASAP before the garbage truck comes"

Jason: "Sorry I'm late, I had to do an improv organ transplant and get rid of a godawful disco suit"

Tim: "Can I get an extension? My brother bought a spleen off the black market and tried to put it in me while I was taking a nap"

Damian: "Who's Robin?"

Duke: "The cast is fake, I'm just wearing it to pick up girls"

Stephanie: *slides over $20*

Cassandra: she just leaves

Barbara: "I have this absolutely real doctor's note because forging medical documents is a crime and I've never committed a crime in my life"

Harper: "I was making spaghetti for the homeless. Try giving me detention now, you ice-blooded bitch"

Carrie: "Can I retake the test later? I accidentally got on a spaceship"

BONUS – Bruce: "…I'm Robin"

[the-mc-riirii]

Some close-ups below

This is based on the marketing lesson where me and my class had to put in our thoughts of an organ transplant campaign before watching the video. I thought it would be a bit hilarious to draw some boxers as these thoughts, so I did.

[justwinginglife]

hi!! may I request something again?^^

may I request soshiro found out that you can turn into a Kaiju or see you transforming into your Kaiju form. a little Angst but with happy ending please:›

You may always request something again! Also story note- for this fic, Imma just ignore that Kikoru Shinomiya exists, sorry yall, you're taking her spot now.

Half Human

Your whole life was one big irony in that your life's mission was to kill kaiju and yet you owed the very breath in your lungs to them. Your father, the Director General, Isao Shinomiya, had already lost his wife and he'd be damned if he was going to lose you too. He secretly brought a kaiju back to base alive and had several talented doctors and scientists exchange its core in place of your failing heart. The doctors weren't even sure it could be done, but when the abomination that was you was finally finished, they were all sworn to secrecy. You were to be the first and the only kaiju transplant survivor.

After all, if word got out that it was possible to enhance the human body directly with kaiju organs, without use of a suit, there would be chaos. For one, the suit industry would take an immense hit and the black market would reign supreme. Not to mention how much ungodly human experimentation could come about from failed attempts to successfully recreate the transplant. It might even make the Defense Force's job more difficult- trying to take Kaiju in alive was significantly more dangerous and strenuous than just killing them.

With all these things in mind, your father kept the tightest lid on the situation. No one but you, your father, and the team that had worked on you knew this secret. But today, one more would find out.

Your father always carefully monitored your vitals in case you ever rejected the organ, and you were always reminded to keep your emotions in check so as to not set off the kaiju side of you. You thought that you'd learned to keep most of your emotions at bay, but apparently that control you had did not apply to anything even remotely related to the Vice Captain.

One time you'd heard someone shit talking him and you accidentally stabbed through your own tongue because your anger had called your fangs to emerge. And it didn't help that the Vice Captain glimpsed the blood dripping from your lips and tried to help you. You always wondered if you'd be able to feel human emotions anymore since you no longer had a human heart, but he quickly put that fear to rest because every time he reached for you, touched you, cared for you, you felt like you could feel your nonexistent heart beating rapidly. It felt like he was the only thing grounding you in your humanity.

Your father must have caught onto this at some point because he'd frequently make excuses to call you to headquarters when he felt like you might be getting too close to Hoshina. Today was one of those days.

You had gotten the summon early this morning and you were annoyed but you knew you that as much as you wanted to rebel against your father as his daughter, as a soldier in his Defense Force you couldn't very well disobey a direct order from the Director General. Especially when no one knew the reason you were called to headquarters so regularly. So you went to him.

By the time you finally concluded your business with your father it was late (you refused to stay the night in his division and let him have anymore hold over your life as it was) and you were waiting for the next train back to the Third Division when you felt your comms buzzing in your pocket. You thought it was strange as everyone should be either asleep or going to sleep soon, but you popped the comms in anyway, eager to hear what was going on so late at night. The base was under attack. It was a Daikaiju. The Vice Captain was fighting him. And losing.

You start to get dizzy. Sweat trickles down your forehead. The world seemed to be blinking in and out. You shake your head trying to get ahold of yourself but you know it's no use. You still haven't learned to get your kaiju side under control and on the rare occasion when you slipped and went berserk only your father could bring you back from that place of darkness. You clench your fists, straining, and gripping onto what was left of your humanity but your lower half had already started to turn.

"No- don't. He needs me. I can't be rampaging in another division right now." You beg the beast inside you.

It doesn't listen.

You feel the transformation reach your neck, a growl already starting to rise up your throat.

"I said stop! Damnit, st-"

Your voice is no longer your own. All that's left of you is one half of your face now, and the beast is slowly closing in on it. It's hungry. It hasn't been let out in awhile.

You look up at the moon, blinking back tears, thinking it might be awhile before you see it again, before you're yourself again. You wonder how long it will take your dad to find you and you wonder if he will even be able to change you back this time. He was getting older, getting weaker. What if you killed him this time?

And what if when you woke up, if you ever woke up again, the Vice Captain was dead? What would you do with your life if you weren't listening for his footsteps in the hallways or listening for his laugh in the air? If he wasn't telling you a joke or complimenting your stance, would you make it through the day? If you went through life not ever having told him how you felt, would it still feel like you were living?

You start to spiral in your own dark thoughts as the transformation spreads across your face, but right before it hits your ear you here the comms crackling.

"Vice Captain! Come in, Vice Captain! Sir, please respond!" Okonogi. She's yelling for the Vice Captain. Something must've happened.

Your vision starts to go red. You punch the lamppost beside you, but you're surprised to find that it's your fist that hits the metal. Not the beast's. You look down. Only your legs are still transformed.

You actually laugh out loud. "That's more like it. Time to go." You jump once, and it propels you into the sky. You use the momentum to launch yourself towards the Third Division. Somehow your legs are faster than a moving train, bringing you bounding towards the training grounds in what seems like no time at all.

Before you can even think about the consequences of being half transformed on base where the officers are literally trained to kill kaiju like you, before you can even think about how your father will probably kill you himself for revealing the secret he's worked so hard to protect, you're already jumping in front of Hoshina as you transform your arms and block a blow that could've been deadly.

He doesn't even have time to be stunned, you're injured.

He jumps to his feet, concern on his face, as you spit blood. You've not fought anything in your kaiju form before (the most you've done is scare the shit out of some pigeons before your father found you and changed you back) and it takes some getting used to.

"Well fuck. That actually hurt, damnit!" You yell at the kaiju. It laughs at you. You raise an eyebrow. It seems to understand you. You're astounded but you don't care to think too much about it before you launch a punch at its abdomen.

It groans but then it chuckles. "Is that the best you've got?"

"Ah so you do talk. That's fucking creepy, not gonna lie." You punch its chest this time.

It staggers backwards and Hoshina takes advantage of the opening, slashing at its legs. It lands on its back.

You hurl yourself high into the air and then crash down hard on its head with a deafening blow that splits its skull. But it starts to slowly regenerate and it shakes you off of it. You land at the ground by Hoshina.

"So are we ever going to talk about the whole 'you being a half kaiju hybrid' thing?" He asks you, eyes still trained on the shuddering beast in front of him.

"Really? Now? We're a little busy Hoshina."

He laughs- he actually fucking laughs. "Oh really, because here I thought we were having a nice little tea party."

You roll your eyes but you can't help but smile at his poor comedic timing. "I'll treat you to some tea if you tell me where the damn core is."

He points to its back. "Lil fucker is hiding it in there."

You nod. "Got it."

The kaiju rises to its feet, ready for another round.

"Do me a favor and be bait, yeah?" You tell Hoshina and then before he can protest, you charge its back.

The kaiju swings at you but you duck.

"Oh I'm the fucking bait? Real classy." Hoshina grumbles but he complies, charging at its front, slashing at it and keeping it busy while you circle behind it.

You run up the stairs of a nearby building and when you reach the top, you launch yourself from the roof.

"This one is for making Hoshina bleed." You mutter under your breath before sending its organs flying as you rip through its flesh and pummel its core to bits. The aftershock sends you flying and you don't have time to land properly. You smack the floor on your side, tumbling in circles until you finally slow.

Your ribs feel like they're caving in but at least the kaiju is down for good. You lie in the dirt, coughing painfully and looking up at the night sky. You're fully human again, like the beast inside you curled up and went to bed, letting you feel the full force of the pain alone.

Hoshina rushes over to you. "Oh my god, are you okay?!"

You cough again. "Not sure if I'm up for that tea party anymore. Might've fucked up a lung or two."

He rolls his eyes. "You would make a joke at a time like this."

"And who was the one asking me stupid questions mid fucking fight?" You tease.

He laughs.

"So... are we going to talk about it now?" You swallow, wondering how he'll react to this new side of you.

He thinks for a moment. "Talk about what? As far as I know, a human saved me from the kaiju. And it looks like," He chucks a rock at the nearby drone, "The rubble badly damaged any footage that might've been captured."

You sigh, relieved, and relax against the ground.

"But... if there's anything you want to tell me later... when you're ready, I'll listen."

There were so many things you wanted to tell him and you being half kaiju was the least important of them. But you'd save that for another day, maybe when less of your limbs hurt.

------------------------------------------------------------------------------

"By the way, did you really brutally murder the kaiju just because it made me bleed? Your comms were on."

"Shut up, Hoshina."

[xoheisse]

russia returns bodies of prisoners of war without internal organs during exchanges, - Ukrinform.

"This confirms the fact that the black market of organ transplants in russia works. And the bodies themselves are returned with signs of torture."

original post

[mitalipingale]

https://www.palscity.com/read-blog/309354_organ-transplant-immunosuppressant-drugs-market-size-analysis-and-forecast-2031.html

The Organ Transplant Immunosuppressant Drugs Market in 2023 is US$ 5.17 billion, and is expected to reach US$ 6.71 billion by 2031 at a CAGR of 3.30%.